Literature DB >> 2531657

Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it.

E M Salonen1, M Jauhiainen, L Zardi, A Vaheri, C Ehnholm.   

Abstract

The plasma concentration of human lipoprotein(a) [Lp(a)] is correlated with the risk of heart disease. A distinct feature of the Lp(a) particle is the apolipoprotein (a) [apo(a)], which is associated with apoB-100, the main protein component of low-density lipoprotein. We now report that apo(a), which has extensive homology to plasminogen, binds to immobilized fibronectin. The binding of Lp(a) was localized to the C-terminal heparin-binding domain of fibronectin. Incubation of Lp(a) with fibronectin resulted in fragmentation of fibronectin. The cleavage pattern, as visualized by gel electrophoresis and immunoblotting, was reproducibly obtained with Lp(a) purified from five different individuals and was distinct from that obtained upon proteolysis of fibronectin by plasmin or kallikrein. The use of synthetic peptide substrates demonstrated that the amino acid specificity for Lp(a) was arginine rather than lysine. The proteolytic activity of Lp(a) was localized to apo(a) and experiments with inhibitors indicated that the proteolytic activity was of serine proteinase-type.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531657      PMCID: PMC401578          DOI: 10.1002/j.1460-2075.1989.tb08586.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.

Authors:  H Pande; J Calaycay; T D Lee; K Legesse; J E Shively; A Siri; L Borsi; L Zardi
Journal:  Eur J Biochem       Date:  1987-01-15

2.  Large-scale procedure for the purification of fibronectin domains.

Authors:  L Borsi; P Castellani; E Balza; A Siri; C Pellecchia; F De Scalzi; L Zardi
Journal:  Anal Biochem       Date:  1986-06       Impact factor: 3.365

3.  Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma.

Authors:  C Ehnholm; H Garoff; O Renkonen; K Simons
Journal:  Biochemistry       Date:  1972-08-15       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Characterization of the Lp(a) lipoprotein in human plasma.

Authors:  K Simons; C Ehnholm; O Renkonen; B Bloth
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

6.  Studies of Lp-lipoprotein as a quantitative genetic trait.

Authors:  N R Harvie; J S Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205

7.  Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen.

Authors:  C Ehnholm; H Garoff; K Simons; H Aro
Journal:  Biochim Biophys Acta       Date:  1971-05-25

8.  Fibronectin in formation and degradation of the pericellular matrix.

Authors:  A Vaheri; E M Salonen; T Vartio
Journal:  Ciba Found Symp       Date:  1985

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Lp(a) lipoprotein as a risk factor for myocardial infarction.

Authors:  G G Rhoads; G Dahlen; K Berg; N E Morton; A L Dannenberg
Journal:  JAMA       Date:  1986-11-14       Impact factor: 56.272

View more
  10 in total

1.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

Authors:  S Pillarisetti; L Paka; J C Obunike; L Berglund; I J Goldberg
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 2.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 3.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

4.  Hypothesis: lipoprotein(a) is a surrogate for ascorbate.

Authors:  M Rath; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Functional heterogeneity of type 1 fimbriae of Escherichia coli.

Authors:  E V Sokurenko; H S Courtney; S N Abraham; P Klemm; D L Hasty
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  LP(a) phenotypes and levels in angiographically proven coronary heart disease patients and controls.

Authors:  K Luthra; S Vasisht; S Chhabra; K R Raju; D P Agarwal; S C Manchanda; L M Srivastava
Journal:  Indian J Clin Biochem       Date:  1998-01

Review 7.  Lipoprotein(a): new insights into an atherogenic lipoprotein.

Authors:  W Bartens; C Wanner
Journal:  Clin Investig       Date:  1994-08

8.  Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates.

Authors:  M Jauhiainen; J Metso; P Koskinen; C Ehnholm
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

9.  Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

Authors:  T F Zioncheck; L M Powell; G C Rice; D L Eaton; R M Lawn
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes.

Authors:  M A Austin; C Sandholzer; J V Selby; B Newman; R M Krauss; G Utermann
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.